trending Market Intelligence /marketintelligence/en/news-insights/trending/ZiY_dp0G3wQ1Lxqmba6khw2 content esgSubNav
In This List

Acer Therapeutics raises another $1.6M in stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Acer Therapeutics raises another $1.6M in stock offering

Acer Therapeutics Inc. said it raised additional gross proceeds of about $1.6 million after the underwriters of its common stock offering partially exercised their overallotment option.

Following the underwriters' purchase of an additional 130,000 shares at $12 apiece, the total number of shares sold increased to 1,046,667 shares and the total gross proceeds increased to $12.6 million.

The company plans to use the net proceeds to fund its research and development efforts, to seek regulatory approval for its product Edsivo, to invest in precommercial activities for Edsivo, and for general corporate purposes, including working capital and other general and administrative purposes.

William Blair & Co. LLC acted as sole book-running manager of the offering. H.C. Wainwright & Co. acted as lead manager of the offering.